August 18, 2011 - A new KLAS report, "Positron Emission Tomography (PET)/Computed Tomography (CT) 2011-New Technologies in Focus," measures the innovative pairing of nuclear medicine scan technologies and reviews of the top three vendors in the market space: GE Healthcare, Philips and Siemens.
August 17, 2011 – THA Group, a free standing in-home health company serving coastal Georgia and South Carolina, announced that it will be partnering with Cardiocom to expand its chronic telehealth program providing advanced home telehealth technology to patients with chronic conditions. Cardiocom is a developer, manufacturer and clinical service provider of telehealth solutions.
August 17, 2011 – Veterinarians at the Phoenix Zoo welcomed the help of the associate chief of cardiovascular surgery at St. Joseph's Heart and Lung Institute of Phoenix, Brian deGuzman, M.D., to perform a delicate surgery on the oldest mandrill in the United States.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
August 17, 2011 – At the 2011 American Hospital Radiology Administrators conference (AHRA), Fujifilm Medical Systems U.S.A. announced its entry into the portable ultrasound market with the commercial availability of the Fazone CB. Designed to meet the needs of the point-of-care and mobile healthcare environments, the Fazone CB is a compact and lightweight unit that produces high-quality images quickly and easily for on-the-go clinicians.
August 17, 2011 — The Society of Cardiovascular Computed Tomography (SCCT) announced the election of James K. Min, M.D., FSCCT, as its new president and John R. Lesser, M.D., FSCCT, as president-elect of the organization. Jeffrey J. Carr, M.D., FSCCT, is the vice president and Ricardo C. Cury, M.D. is joining the executive committee as treasurer. The announcement was made official at the sixth annual scientific meeting, recently held in Denver, Colo.
August 17, 2011 — A scientist at the Gladstone Institutes has discovered how a gene known as SIRT3 contributes to a suite of health problems, offering new insight into how to combat these potentially fatal conditions.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
August 17, 2011 — OrbusNeich announced its Genous stent showed no significant difference in target vessel failure (TVF) rate at two years from the Taxus Liberte paclitaxel-eluting stent in patients with de novo coronary artery lesions at high risk for restenosis. The two-year follow-up data from the prospective, randomized TRIAS pilot study were published in Catheterization and Cardiovascular Interventions.
August 17, 2011 — Our Lady of Lourdes Medical Center performed its first “hybrid” heart surgery and what is believed to be the first such procedure in southern New Jersey. Arthur T. Martella, M.D., chief of cardiothoracic surgery at Lourdes, and Anil G. Kothari, M.D., FACC, FSCA & I of Lourdes Health System affiliate South Jersey Heart Group, performed the procedure.
August 17, 2011 – Enhanced communication, accessibility to remote physicians and improved workflow are some of the benefits that hospitals and radiology departments can expect to gain from MD2GO, a new remote HD IP camera system from Sony Medical. Making its debut to the field of radiology during the Annual Meeting of the Association for Medical Imaging Management (AHRA), Dallas, Texas, Aug. 14 – 17, MD2GO leverages Sony’s leading visual imaging technologies to bring advanced communication to radiology.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
August 17, 2011 – Abbott announced today that the first patient in Japan has been treated with the Absorb bioresorbable vascular scaffold (BVS) as part of the ABSORB EXTEND clinical trial. Abbott's BVS restores blood flow by opening a clogged vessel and providing support to the vessel until the device dissolves within approximately two years, leaving patients with a treated vessel free of a permanent metallic implant. The device received CE Mark approval in the European Union (EU) for the treatment of coronary artery disease and is under clinical investigation in several countries around the world. The first patient in Japan was treated in the ABSORB EXTEND clinical trial by Shigeru Saito, M.D., director, Cardiology and Catheterization Laboratories, and vice president, Shonan Kamakura Hospital, Kanagawa, Japan.
August 16, 2011 — Vital Images Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for VitreaView, a new universal viewer providing uniform access to all images within patient imaging. VitreaView is designed for access through the electronic medical record (EMR), electronic health record (EHR) and health information exchange (HIE). Vital Images is a Toshiba Medical Systems Group company.
August 12, 2011— Simbionix USA Corp., a provider of medical simulation training and education products for medical professionals and the healthcare industry, has been granted a patent in the United Kingdom for its innovative Procedure Rehearsal Studio.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
August 12, 2011 — Endologix Inc. announced that the first American commercial implant of the company's AFX Endovascular AAA system was performed at Edward Hines, Jr. VA Hospital in Chicago. Ross Milner, M.D., F.A.C.S., associate professor and chief of vascular surgery & endovascular therapy at Loyola University Chicago performed the procedure.
August 12, 2011 — SynCardia Systems Inc., manufacturer of the temporary Total Artificial Heart (TAH). said Aug. 2, Papworth Hospital in Cambridge discharged the United Kingdom's first TAH patient. He was sent home to wait for a matching donor heart with his wife and 5-year-old son using the Freedom portable driver.
August 11, 2011 — A physician studying the link between behavior and diet and exercise in African-American men is the inaugural recipient of the first award issued by the Coalition to Reduce Disparities in Cardiovascular Disease Outcomes, or CREDO. The coalition is part of the American College of Cardiology (ACC).